- Home
- ICLR vs NWS Comparison
ICLR vs NWS Comparison
Compare ICLR & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- NWS
- Stock Information
- Founded
- ICLR 1990
- NWS 2012
- Country
- ICLR Ireland
- NWS United States
- Employees
- ICLR N/A
- NWS N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- NWS Newspapers/Magazines
- Sector
- ICLR Health Care
- NWS Consumer Discretionary
- Exchange
- ICLR Nasdaq
- NWS Nasdaq
- Market Cap
- ICLR 14.3B
- NWS 16.8B
- IPO Year
- ICLR 1998
- NWS N/A
- Fundamental
- Price
- ICLR $178.10
- NWS $30.20
- Analyst Decision
- ICLR Buy
- NWS Strong Buy
- Analyst Count
- ICLR 15
- NWS 7
- Target Price
- ICLR $211.36
- NWS $38.28
- AVG Volume (30 Days)
- ICLR 1.0M
- NWS 1.2M
- Earning Date
- ICLR 10-22-2025
- NWS 11-07-2025
- Dividend Yield
- ICLR N/A
- NWS 0.66%
- EPS Growth
- ICLR N/A
- NWS 345.01
- EPS
- ICLR 7.47
- NWS 2.07
- Revenue
- ICLR $8,102,602,000.00
- NWS $8,452,000,000.00
- Revenue This Year
- ICLR N/A
- NWS $4.61
- Revenue Next Year
- ICLR $1.68
- NWS $3.46
- P/E Ratio
- ICLR $24.08
- NWS $13.14
- Revenue Growth
- ICLR N/A
- NWS 2.42
- 52 Week Low
- ICLR $125.10
- NWS $26.25
- 52 Week High
- ICLR $242.72
- NWS $35.58
- Technical
- Relative Strength Index (RSI)
- ICLR 45.22
- NWS 39.36
- Support Level
- ICLR $173.47
- NWS $29.77
- Resistance Level
- ICLR $198.30
- NWS $30.33
- Average True Range (ATR)
- ICLR 7.63
- NWS 0.57
- MACD
- ICLR -1.08
- NWS 0.06
- Stochastic Oscillator
- ICLR 18.63
- NWS 38.31
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About NWS News Corporation Class B
News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.